|
1.
|
|
13 p, 2.2 MB |
Monitoring EGFR -T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer
/
Morán, Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Felip, Eudald (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Bosch-Barrera, Joaquim (Medical Oncology Department, Catalan Institute of Oncology-Girona, Hospital Universitari Doctor Trueta Girona, Girona, Spain) ;
de Aguirre, Itziar (Institut Germans Trias i Pujol) ;
Ramirez, Jose Luis (Institut Germans Trias i Pujol) ;
Mesia, Carles (Medical Oncology Department, Catalan Institute of Oncology - Hospital Duran i Reynalds, l'Hospitalet de Llobregat, Barcelona, Spain) ;
Carcereny, Enric (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Roa, Diana (Medical Oncology Department, Catalan Institute of Oncology-Girona, Hospital Universitari Doctor Trueta Girona, Girona, Spain) ;
Sais, Elia (Medical Oncology Department, Catalan Institute of Oncology-Girona, Hospital Universitari Doctor Trueta Girona, Girona, Spain) ;
García García, Yolanda (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Blanco, Remei (Medical Oncology Department, Consorci Sanitari de Terrassa, Terrassa, Barcelona, Spain) ;
Sanchez, Silvia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Villacorta, Claudia Rosa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Queralt, C. (Institut Germans Trias i Pujol) ;
Velarde, Jose María (Institut Germans Trias i Pujol) ;
Rosell, Rafael (Institut Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona
Osimertinib is efficacious in lung cancer patients with epidermal growth factor receptor (EGFR) mutations and acquired resistance (AR) to EGFR tyrosine kinase inhibitors due to EGFR -T790M mutation (T790M). [...]
2018 -  10.18632/oncotarget.25478
Oncotarget, Vol. 9 (june 2018) , p. 27074-27086
|
|
|
2.
|
|
14 p, 572.1 KB |
Molecular profiling of long-term responders to immune checkpoint inhibitors in advanced non-small cell lung cancer
/
Frigola Rissech, Joan (VHIO) ;
Navarro, Alejandro (VHIO) ;
Carbonell, Caterina (VHIO) ;
Callejo, Anna (VHIO) ;
Iranzo, Patricia (VHIO) ;
Cedrés, Susana (VHIO) ;
Martinez-Martí, Alex (VHIO) ;
Pardo, Nuria (VHIO) ;
Saoudi-Gonzalez, Nadia (VHIO) ;
Martinez, D. (Translational Genomics and Targeted Therapies in Solid Tumors. IDIBAPS) ;
Jiménez, José (VHIO) ;
Sansano, Irene (Hospital Universitari Vall d'Hebron) ;
Mancuso, Francesco M. (VHIO) ;
Nuciforo, Paolo (VHIO) ;
Montuenga, L.M. (Navarra Health Research Institute (IDISNA)) ;
Sánchez-Cespedes, Montse (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Prat, A. (Translational Genomics and Targeted Therapies in Solid Tumors. IDIBAPS) ;
Vivancos, Ana (VHIO) ;
Felip, Enriqueta (VHIO) ;
Amat, Ramón (VHIO) ;
Universitat Autònoma de Barcelona
Immunotherapy has transformed advanced non-small cell lung cancer (NSCLC) treatment strategies and has led to unprecedented long-lasting responses in some patients. However, the molecular determinants driving these long-term responses remain elusive. [...]
2020 - 10.1002/1878-0261.12891
Molecular Oncology, 2020
|
|
|
3.
|
|
11 p, 515.9 KB |
Study of the Spanish Society of Medical Oncology (SEOM) on the access to oncology drugs and predictive biomarkers in Spain
/
Rodríguez-Lescure, A. (Hospital General Universitario de Elche. Medical Oncology Department) ;
de la Peña, F. A. (Hospital Universitario Morales Meseguer. Haematology and Medical Oncology Department) ;
Aranda, E. (Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III. Oncology Department) ;
Calvo, A. (Hospital General Universitario Gregorio Marañón) ;
Felip, E. (Hospital Universitari Vall d'Hebron) ;
Garrido, P. (Hospital Universitario Ramón Y Cajal. Medical Oncology Department) ;
Vera, R. (Complejo Hospitalario de Navarra, Navarrabiomed, IdISNA. Medical Oncology Department) ;
Universitat Autònoma de Barcelona
The Spanish Society of Medical Oncology (SEOM) has carried out a study to analyse the conditions of access to oncology drugs in clinical practice in Spain. For the first time, the access of predictive biomarkers has also been analyzed. [...]
2020 - 10.1007/s12094-020-02366-y
Clinical & Translational Oncology, Vol. 22 (june 2020) , p. 2253-2263
|
|
|
4.
|
|
1 p, 789.3 KB |
Correction : Monitoring EGFR -T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer
/
Morán, Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Felip, Eudald (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Bosch-Barrera, Joaquim (Medical Oncology Department, Catalan Institute of Oncology-Girona, Hospital Universitari Doctor Trueta Girona, Girona, Spain) ;
de Aguirre, Itziar (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ramirez, Jose Luis (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Mesia, Carles (Medical Oncology Department, Catalan Institute of Oncology - Hospital Duran i Reynalds, l'Hospitalet de Llobregat, Barcelona, Spain.) ;
Carcereny, Enric (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Roa, Diana (Medical Oncology Department, Catalan Institute of Oncology-Girona, Hospital Universitari Doctor Trueta Girona, Girona, Spain.) ;
Sais, Elia (Medical Oncology Department, Catalan Institute of Oncology-Girona, Hospital Universitari Doctor Trueta Girona, Girona, Spain.) ;
García García, Yolanda (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Blanco, Remei (Medical Oncology Department, Consorci Sanitari de Terrassa, Terrassa, Barcelona, Spain) ;
Sanchez, Silvia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Villacorta, Claudia Rosa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Queralt, C. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Velarde, Jose María (Institut Germans Trias i Pujol) ;
Rosell, Rafael (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Universitat Autònoma de Barcelona
2019 - 10.18632/oncotarget.26855
Oncotarget, Vol. 10 (april 2019) , p. 2576
|
|
|
5.
|
|
|
6.
|
|
13 p, 2.1 MB |
Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non-Small Cell Lung Carcinoma : the ROSING Study
/
Conde, E. (HM Sanchinarro University Hospital-CIBERONC) ;
Hernández, Susana (HM Sanchinarro University Hospital) ;
Martinez, R. (HM Sanchinarro University Hospital) ;
Angulo, B. (HM Sanchinarro University Hospital-CIBERONC) ;
De Castro, J. (La Paz University Hospital) ;
Collazo-Lorduy, A. (HM Sanchinarro University Hospital) ;
Jimenez, B. (HM Sanchinarro University Hospital) ;
Muriel, A. (Ramon y Cajal University Hospital. IRYCIS and CIBERESP) ;
Mate Sanz, Jose Luís (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Morán, Teresa (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Aranda, I. (General University Hospital-ISABIAL) ;
Massuti, B. (General University Hospital-ISABIAL) ;
Rojo, F. (Institute of Health Research-Jimenez Diaz Foundation-CIBERONC) ;
Domine, M. (Institute of Health Research-Jimenez Diaz Foundation) ;
Sansano, Irene (Hospital Universitari Vall d'Hebron) ;
Garcia, F. (Quironsalud Hospital) ;
Felip, Enriqueta (Hospital Universitari Vall d'Hebron) ;
Mancheño, N. (La Fe University Hospital) ;
Juan, O. (La Fe University Hospital) ;
Sanz, Julián (Clinico San Carlos University Hospital) ;
Gonzalez-Larriba, J.L. (Clinico San Carlos University Hospital) ;
Atienza-Cuevas, L. (Puerta del Mar University Hospital) ;
Arriola-Arellano, E. (Puerta del Mar University Hospital) ;
Abdulkader, I. (Clinico de Santiago University Hospital) ;
Garcia-Gonzalez, J. (Clinico de Santiago University Hospital) ;
Camacho, C. (Insular Materno-Infantil University Hospital Complex) ;
Rodriguez-Abreu, D. (Insular Materno-Infantil University Hospital Complex) ;
Teixido, C. (Clinic Hospital) ;
Reguart, Noemi (Clinic Hospital) ;
Gonzalez-Piñeiro, A. (Alvaro Cunqueiro Hospital) ;
Lazaro-Quintela, M. (Alvaro Cunqueiro Hospital) ;
Lozano, M.D. (University of Navarra Clinic) ;
Gurpide, A. (University of Navarra Clinic) ;
Gomez-Roman, J. (Marques de Valdecilla University Hospital) ;
Lopez-Brea, M. (Marques de Valdecilla University Hospital) ;
Pijuan, Lara (Hospital del Mar (Barcelona, Catalunya)) ;
Salido, Marta (Hospital del Mar (Barcelona, Catalunya)) ;
Arriola, Edurne (Hospital del Mar (Barcelona, Catalunya)) ;
Company, A. (Clinico University Hospital) ;
Insa, A. (Clinico University Hospital) ;
Esteban-Rodriguez, I. (La Paz University Hospital) ;
Saiz, M. (Cruces University Hospital) ;
Azkona, E. (Cruces University Hospital) ;
Alvarez, R. (Miguel Servet University Hospital) ;
Artal, A. (Miguel Servet University Hospital) ;
Plaza, M.L. (University Hospital of Gran Canaria Doctor Negrin) ;
Aguiar, D. (University Hospital of Gran Canaria Doctor Negrin) ;
Enguita, A.B. (12 de Octubre University Hospital) ;
Benito, A. (Ramon y Cajal University Hospital) ;
Paz-Ares, L. (12 de Octubre University Hospital-CIBERONC) ;
Garrido, P. (Ramon y Cajal University Hospital-CIBERONC) ;
Lopez-Rios, F. (HM Sanchinarro University Hospital-CIBERONC) ;
Universitat Autònoma de Barcelona
Introduction: The ROS1 gene rearrangement has become an important biomarker in NSCLC. The College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology testing guidelines support the use of ROS1 immunohistochemistry (IHC) as a screening test, followed by confirmation with fluorescence in situ hybridization (FISH) or a molecular test in all positive results. [...]
2019 - 10.1016/j.jtho.2019.07.005
Journal of Thoracic Oncology, Vol. 14 Núm. 12 (december 2019) , p. 2120-2132
|
|
|
7.
|
|
19 p, 2.6 MB |
Pharmacological modulation of SAMHD1 activity by CDK4/6 inhibitors improves anticancer therapy
/
Castellví, Marc (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Felip, Eudald (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ezeonwumelu, Ifeanyi Jude (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Badia, Roger (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Garcia-Vidal, Edurne (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Pujantell, Maria (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Gutiérrez-Chamorro, Lucía (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Teruel, Iris (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Martínez Cardús, Anna (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Clotet, Bonaventura (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Riveira-Muñoz, Eva (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Margelí, Mireia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ballana, Ester (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Universitat Autònoma de Barcelona
Sterile alpha motif and histidine-aspartic acid domain-containing protein 1 (SAMHD1) is a dNTP triphosphohydrolase involved in the regulation of the intracellular dNTP pool, linked to viral restriction, cancer development and autoimmune disorders. [...]
2020 - 10.3390/cancers12030713
Cancers, Vol. 12 Núm. 3 (march 2020) , p. 713
|
|
|
8.
|
|
23 p, 695.6 KB |
Noves aportacions al coneixement de la flora cormofítica de les comarques meridionals de Catalunya, amb especial atenció a les muntanyes de Prades
/
Molero, Julià (Universitat de Barcelona. Facultat de Farmàcia. Laboratori de Botànica) ;
Pyke, Samuel (Jardí Botànic de Barcelona) ;
Guardiola, Moisès ;
Josa, Eloi (Generalitat de Catalunya. Paratge Natural de Poblet) ;
López Alvarado, Javier (Universitat Autònoma de Barcelona. Departament de Biologia Animal, de Biologia Vegetal i d'Ecologia) ;
Felip, Joan ;
Sáez, Llorenç (Universitat Autònoma de Barcelona. Departament de Biologia Animal, de Biologia Vegetal i d'Ecologia)
Aportem noves dades corològiques, taxonòmiques i d'interès per a 73 tàxons provinents del territori Catalanídic Central comprès entre les muntanyes de Prades i el riu Ebre. En l'aspecte corològic destaca Poa trivialis subsp. [...]
We provide new chorological, taxonomic and other data for 73 taxa found in the Southern Catalonia, which comprises the area between the Prades massif and the river Ebre. As regards chorology, Poa trivialis subsp. [...]
2015
Butlletí de la Institució Catalana d'Història Natural, Núm. 79 (2015) , p. 15-37
|
|
|
9.
|
|
42 p, 308.0 KB |
Del memorialismo analógico al memorialismo digital : aportaciones no-androcéntricas a la construcción de un humanismo plural
/
Moreno, Amparo, 1947- (Universitat Autònoma de Barcelona. Departament de Periodisme i de Ciències de la Comunicació) ;
Gascon, Felip ;
Molina Rodríguez-Navas, Pedro (Universitat Autònoma de Barcelona. Departament de Periodisme i de Ciències de la Comunicació)
Un humanismo plural ha de reconocer la diversidad de memorias y de conocimientos sociales, siendo así la base para nuevas formas de democracia participativa. La crítica al pensamiento académico, junto con el análisis de la implantación de las redes de comunicación y de su alcance en las prácticas cotidianas, clarifica el sistema de relaciones sociales y sus transformaciones. [...]
A plural humanism must recognize the diversity of memoirs and social knowledge, making it the basis for new forms of participatory democracy. The criticism of academic thought, together with the analysis of the implementation of communication networks and their impact on everyday practices, clarifies the system of social relationships and their transformations. [...]
2010
Ghrebh-, núm. 16 (2010) p. 155-198
|
|
|
10.
|
|
40 p, 1.8 MB |
Self-Arranged Misfit Dislocation Network Formation upon Strain Release in La0.7Sr0.3MnO3/LaAlO3(100) Epitaxial Films under Compressive Strain
/
Santiso, José (Institut Català de Nanociència i Nanotecnologia) ;
Roqueta, Jaume (Institut Català de Nanociència i Nanotecnologia) ;
Bagués Salgueró, Núria (Institut Català de Nanociència i Nanotecnologia) ;
Frontera, Carlos (Institut de Ciència de Materials de Barcelona) ;
Konstantinović, Zorica (University of Belgrade. Center for Solid State Physics and New Materials) ;
Lu, Qiyang (Massachusetts Institute of Technology) ;
Yildiz, Bilge (Massachusetts Institute of Technology) ;
Martínez, Benjamín (Institut de Ciència de Materials de Barcelona) ;
Pomar, Alberto (Institut de Ciència de Materials de Barcelona) ;
Balcells Argemí, Lluís (Institut de Ciència de Materials de Barcelona) ;
Sandiumenge Ortiz, Felip (Institut de Ciència de Materials de Barcelona)
Lattice-mismatched epitaxial films of LaSrMnO (LSMO) on LaAlO (001) substrates develop a crossed pattern of misfit dislocations above a critical thickness of 2. 5 nm. Upon film thickness increases, the dislocation density progressively increases, and the dislocation spacing distribution becomes narrower. [...]
2016 - 10.1021/acsami.6b02896
ACS applied materials & interfaces, Vol. 8, Issue 26 (July 2016) , p. 16823-16832
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
